ARTICLE · 26 SEPTEMBER 2023
FTC Targets Private Equity In Challenge To Anesthesiology Roll-Ups
On September 21, 2023, the Federal Trade Commission (FTC) sued U.S. Anesthesia Partners Inc. (USAP) and Welsh, Carson, Anderson & Stowe XI L.P., among other private equity funds, in the United States District Court for the Southern District of Texas under the antitrust laws.
United StatesAntitrust/Competition Law
On September 21, 2023, the Federal Trade Commission (FTC) sued U.S. Anesthesia Partners
Inc. (USAP) and Welsh, Carson, Anderson & Stowe XI L.P.
(collectively, with other private equity fund defendants,
"Welsh Carson"), among other private equity funds, in the
United States District Court for the Southern District of Texas
under the antitrust laws. Specifically, the FTC alleges that USAP
and Welsh Carson engaged in an anti-competitive scheme to
consolidate anesthesia practices in Texas and to force other
independent anesthesia groups into price-setting arrangements that
violated Section 2 of the Sherman Act, Section 7 of the Clayton Act
and Section 5 of the FTC Act.
Key Takeaways
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.
View source